SANGUINE CORP. (SGNC)
Due to the overwhelming renewed interest in (SGNC), this thread should be helpful as a forum for Information & Discussion.
SANGUINE CORP. (SGNC) a California corporation is engaged in the development of a synthetic red blood cell product called "PHER-02." Management believes the PHER-02 has advantages over human blood: It can be sterilized to be free of disease including (HIV): is belived to have the quality of a universal match for all blood types: can be mass-produced: and may be stored much longer than human blood. Sanguine estimates the annual market potential for this product at $20 billion.
Dr. Thomas C. Drees: Company President & Chief Executive Officer
For an excellent overview on SGNC, see:
Message 5239634
Visit Unofficial SGNC WebPage at: sanguine-corp.com |
